Table 6.

CGI-S. VGF e WHOQOL-BREF Scores at 6 and 12-Month AP-LAI Treatments

Scales	Treatment Duration	Patients Treated with HAL-D (N)	Patients Treated with PP1M (N)	Patients Treated with PP3M (N)	Statistical Test, Probability
CGI-S (m±SD)	6 months	N=35	N=26	N=26	ANOVA
		2.48±1.12	2.58±1.03	2.23±1.18	NS
	12 months	N=34	N=17	N=22	ANOVA
		2.32±0.88	2.47±1.01	2.18±1.05	NS
GAF (m±SD)	6 months	N=35	N=26	N=26	ANOVA
		64.57±14.37	672.5±14.09	71.54±13.98	NS
	12 months	N=34	N=17	N=22	ANOVA
		64.26±13.44	66.18±14.74	71.13±13.97	NS
WHOQOL-BREF: quality of life (m±SD)	6 months	N=35	N=26	N=26	ANOVA
		3.45±0.96	3.59±0.51	3.91±0.96	NS
	12 months	N=34	N=17	N=22	ANOVA
		3.65±0.75	4±0.5	3.77±0.69	NS
WHOQOL-BREF: health satisfaction (m±SD)	6 months	N=35	N=26	N=26	ANOVA
		3.45±0.96	3.35±0.93	3.73±0.55	NS
	12 months	N=34	N=17	N=22	ANOVA
		3.58±0.85	3.71±0.75	3.91±1.03	NS
WHOQOL-BREF total (m±SD)	6 months	N=35	N=26	N=26	ANOVA
		54.94±7.72	52±8.65	55.23±6.77	NS
	12 months	N=34	N=17	N=22	ANOVA
		55.18±9.78	57.91±7.66	55.68±9.84	NS

Note: NS=Not Significant.